• Rituximab in Childhood Lupus: Insights and Safety

  • 2025/01/06
  • 再生時間： 15 分
  • ポッドキャスト

Rituximab in Childhood Lupus: Insights and Safety

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Join Dr. Anna Wolska and Dr. Jordan Roberts, a pediatric rheumatologist, as they explore the use of Rituximab in treating childhood-onset systemic lupus erythematosus (SLE). They discuss key factors for healthcare providers when prescribing Rituximab to children and adolescents, especially for severe cases like lupus nephritis and CNS involvement. Dr. Roberts presents recent research on Rituximab’s safety, highlighting increased infection risks and the need for targeted prevention strategies. Tune in for expert insights on the latest advancements, challenges, and future directions in pediatric lupus treatment.

    Read the paper published in LSM - https://doi.org/10.1136/lupus-2024-001210
    続きを読む 一部表示

あらすじ・解説

Join Dr. Anna Wolska and Dr. Jordan Roberts, a pediatric rheumatologist, as they explore the use of Rituximab in treating childhood-onset systemic lupus erythematosus (SLE). They discuss key factors for healthcare providers when prescribing Rituximab to children and adolescents, especially for severe cases like lupus nephritis and CNS involvement. Dr. Roberts presents recent research on Rituximab’s safety, highlighting increased infection risks and the need for targeted prevention strategies. Tune in for expert insights on the latest advancements, challenges, and future directions in pediatric lupus treatment.

Read the paper published in LSM - https://doi.org/10.1136/lupus-2024-001210
続きを読む 一部表示

Rituximab in Childhood Lupus: Insights and Safetyに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。